Approval of Vykat XR marks the first treatment indicated for hyperphagia in patients with Prader-Willi syndrome.

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

Dr. Shivaani Kummar is stepping into the role of OHSU Knight Cancer Institute chief executive on an interim basis, OHSU ...

Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster their global competitiveness.

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investo ...

President and CEO of Trevi Therapeutics. "With Haduvio, we are looking to address a significant unmet need across chronic cough conditions where there are no therapies approved in the U.S. Haduvio ...

and I believe this transaction will maximize value for our stockholders and provide accelerated access to Unloxcyt in the United States, Europe, and other markets worldwide." 1. Sun Pharma to Acquire ...

President & CEO of Arcturus Therapeutics. "Arcturus continues to make excellent progress with our STARR® sa-mRNA vaccines pipeline and platform. We are very pleased to have recently received ...

Ajan Reginald, Roquefort Therapeutics CEO commented: "We are pleased that ... as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR").

Ajan Reginald, Roquefort Therapeutics CEO commented: "We are pleased that ... as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR").